Results 61 to 70 of about 66,673 (183)

Challenges in the Diagnosis of Cutaneous Mastocytosis

Diagnostics
Background: Mastocytosis is characterized by an accumulation of clonal mast cells (MCs) in tissues such as the skin. Skin lesions in mastocytosis may be clinically subtle or heterogeneous, and giving the correct diagnosis can be difficult.
Knut Brockow, Rebekka Karolin Bent, Simon Schneider, Sophie Spies, Katja Kranen, Benedikt Hindelang, Zsuzsanna Kurgyis, Sigurd Broesby-Olsen, Tilo Biedermann, Clive E. Grattan   +9 more
doaj   +1 more source

Development and validation of a quality of life scale for pediatric mastocytosis

Allergy, Asthma & Clinical Immunology
Background Mastocytosis imposes a considerable burden on patients’ quality of life. While validated QoL instruments are available for adults with systemic mastocytosis, no disease-specific quality-of-life measure has yet been developed for pediatric ...
Aslı Berivan Topçak, Ece Tüsüz Önata, Şeyma Genç, Sefika Ilknur Kökcü Karadag, Nilay Çalışkan, Güler Yıldırım, Hamit Boloğur, Hilal Güngör, Merve Karaca Şahin, Muhammed Fatih Erbay, Hasan Tunç Şarman, Özlem Terzi, Emek Kocatürk, Frank Siebenhaar, Öner Özdemir, Deniz Özçeker   +15 more
doaj   +1 more source

Gastrointestinal tract involvement in systemic mastocytosis: a clinical case

Patologìâ
Mastocytosis is a group of rare heterogeneous diseases caused by excessive proliferation and accumulation of mast cells in various organs and systems.
Ya. S. Bereznytskyi, O. V. Simonova , T. Y. Boiko, H. V. Tuzko, H. S. Lapsar, S. A. Simonova   +5 more
doaj   +1 more source

Nodular mastocytosis: a case study

Vestnik Dermatologii i Venerologii, 2017
A case study of nodular mastocytosis is described. Tacrolimus was used to treat skin manifestations of mastocytosis.
E. V. Pavlova, I. V. Ulitina, YU. E. Rusak, E. N. Efanova, E. N. Ivannikova   +4 more
doaj   +1 more source

Pediatric Mastocytosis

Journal of Investigative Dermatology, 1991
The onset of mastocytosis occurs between birth and 2 years of age in approximately 55% of all cases; an additional 10% develop the disease before the age of 15 years. Mastocytosis in these age groups differs in many respects from mastocytosis that has its onset in adulthood. The typical presentation of pediatric-onset mastocytosis consists of cutaneous
Kettelhut, Brett V., Metcalfe, Dean D.
openaire   +4 more sources

Diffuse large B cell lymphoma coexistence with systemic mastocytosis

Journal of Cancer Research and Practice, 2016
Systemic mastocytosis is a rare disease and characterized by excessive mast cell accumulation in one or multiple organs. One subtype of systemic mastocytosis is systemic mastocytosis-associated clonal hematological non-mast cell lineage disease (SM-AHMND)
Sheng-Hsuan Chien, Yao-Chung Liu, Ying-Chung Hong, Ching-Fen Yang, Chun-Yu Liu, Tzeon-Jye Chiou, Cheng-Hwai Tzeng, Jin-Hwang Liu, Jyh-Pyng Gau   +8 more
doaj   +1 more source

Enhanced PIEZO1 expression in mast cells of mastocytosis skin lesions: Relevance to Darier's sign

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 7, Page e598-e601, July 2026.
Yoshiaki Kobayashi, Nobuhiro Nakano, Nguyen Quoc Vuong Tran, Yuki Nakamura, Lisa Minai, Takashi Okamoto, Daiki Nakagomi, Tatsuki R. Kataoka, Tatsuyoshi Kawamura, Atsuhito Nakao   +9 more
wiley   +1 more source

A rare case of the cutaneous form of mastocytosis in a Sakha child

Якутский медицинский журнал
The article is devoted to a rare disease which is mastocytosis in a child. In Russia, this disease is registered with a frequency of 0.12–1 case per 1000.
O. N. Ivanova, S. A. Evseeva, I. S. Ivanova, T. E. Burtseva   +3 more
doaj   +1 more source

Cutaneous and Gastrointestinal Symptoms in Two Patients with Systemic Mastocytosis Successfully Treated with Omalizumab

Case Reports in Medicine, 2015
The pathogenesis of mastocytosis is not well defined and thus treatment remains challenging and remains on a palliative basis. We present two cases (a 48-year-old woman and a 57-year-old man) with indolent systemic mastocytosis in whom omalizumab (anti ...
Sofie Lieberoth, Simon Francis Thomsen
doaj   +1 more source

Issue Information

Cancer Nexus, Volume 2, Issue 3, July 2026.
No abstract is available for this article.
wiley   +1 more source